277 related articles for article (PubMed ID: 19117948)
1. PTEN, stem cells, and cancer stem cells.
Hill R; Wu H
J Biol Chem; 2009 May; 284(18):11755-9. PubMed ID: 19117948
[TBL] [Abstract][Full Text] [Related]
2. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.
Korkaya H; Paulson A; Charafe-Jauffret E; Ginestier C; Brown M; Dutcher J; Clouthier SG; Wicha MS
PLoS Biol; 2009 Jun; 7(6):e1000121. PubMed ID: 19492080
[TBL] [Abstract][Full Text] [Related]
3. Methods for PTEN in Stem Cells and Cancer Stem Cells.
Schubbert S; Jiao J; Ruscetti M; Nakashima J; Wu S; Lei H; Xu Q; Yi W; Zhu H; Wu H
Methods Mol Biol; 2016; 1388():233-85. PubMed ID: 27033080
[TBL] [Abstract][Full Text] [Related]
4. PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting.
Ciuffreda L; Falcone I; Incani UC; Del Curatolo A; Conciatori F; Matteoni S; Vari S; Vaccaro V; Cognetti F; Milella M
Adv Biol Regul; 2014 Sep; 56():66-80. PubMed ID: 25088603
[TBL] [Abstract][Full Text] [Related]
5. PTEN regulates BCRP/ABCG2 and the side population through the PI3K/Akt pathway in chronic myeloid leukemia.
Huang FF; Zhang L; Wu DS; Yuan XY; Yu YH; Zhao XL; Chen FP; Zeng H
PLoS One; 2014; 9(3):e88298. PubMed ID: 24603487
[TBL] [Abstract][Full Text] [Related]
6. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance.
Zhou J; Wulfkuhle J; Zhang H; Gu P; Yang Y; Deng J; Margolick JB; Liotta LA; Petricoin E; Zhang Y
Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16158-63. PubMed ID: 17911267
[TBL] [Abstract][Full Text] [Related]
7. PTEN: an intercellular peacekeeper?
Leslie NR
Sci Signal; 2012 Nov; 5(250):pe50. PubMed ID: 23150879
[TBL] [Abstract][Full Text] [Related]
8. miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation.
Li B; Lu Y; Yu L; Han X; Wang H; Mao J; Shen J; Wang B; Tang J; Li C; Song B
Chem Biol Interact; 2017 Nov; 277():33-42. PubMed ID: 28844858
[TBL] [Abstract][Full Text] [Related]
9. PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry.
Groszer M; Erickson R; Scripture-Adams DD; Dougherty JD; Le Belle J; Zack JA; Geschwind DH; Liu X; Kornblum HI; Wu H
Proc Natl Acad Sci U S A; 2006 Jan; 103(1):111-6. PubMed ID: 16373498
[TBL] [Abstract][Full Text] [Related]
10. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
11. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
12. NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway.
He W; Cheng F; Zheng B; Wang J; Zhao G; Yao Z; Zhang T
Aging (Albany NY); 2021 May; 13(10):14015-14038. PubMed ID: 34030133
[TBL] [Abstract][Full Text] [Related]
13. Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival.
Baker A; Wyatt D; Bocchetta M; Li J; Filipovic A; Green A; Peiffer DS; Fuqua S; Miele L; Albain KS; Osipo C
Oncogene; 2018 Aug; 37(33):4489-4504. PubMed ID: 29743588
[TBL] [Abstract][Full Text] [Related]
14. PTEN in the haematopoietic system and its therapeutic indications.
Cheung AM; Mak TW
Trends Mol Med; 2006 Nov; 12(11):503-5. PubMed ID: 16996801
[TBL] [Abstract][Full Text] [Related]
15. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.
Kakarala M; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2813-20. PubMed ID: 18539959
[TBL] [Abstract][Full Text] [Related]
16. TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivation.
Morris SM; Carter KT; Baek JY; Koszarek A; Yeh MM; Knoblaugh SE; Grady WM
Oncogene; 2015 Jun; 34(25):3273-82. PubMed ID: 25132272
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic niches are endowed with a protumorigenic mechanism that supersedes the protective function of PTEN.
Nascimento-Filho CHV; Webber LP; Borgato GB; Goloni-Bertollo EM; Squarize CH; Castilho RM
FASEB J; 2019 Dec; 33(12):13435-13449. PubMed ID: 31560860
[TBL] [Abstract][Full Text] [Related]
18. PTEN and leukemia stem cells.
Fragoso R; Barata JT
Adv Biol Regul; 2014 Sep; 56():22-9. PubMed ID: 24961634
[TBL] [Abstract][Full Text] [Related]
19. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations.
Dubrovska A; Kim S; Salamone RJ; Walker JR; Maira SM; García-Echeverría C; Schultz PG; Reddy VA
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):268-73. PubMed ID: 19116269
[TBL] [Abstract][Full Text] [Related]
20. Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma.
Cheng Y; Cheung AK; Ko JM; Phoon YP; Chiu PM; Lo PH; Waterman ML; Lung ML
BMC Cell Biol; 2013 Sep; 14():44. PubMed ID: 24073846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
